Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,206.40
(
0.01%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
100.04
(
-1.15%
)
Bitcoin
77,981.02
(
-0.38%
)
News Focus
News Focus
Post# of 21574
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

InTheTrenches

Send PM Follow Ignore
Followers 4
Posts 929
Boards Moderated 0
Alias Born 08/15/2006

InTheTrenches

Re: runncoach post# 8966

Sunday, 03/24/2019 1:40:17 PM

Sunday, March 24, 2019 1:40:17 PM

Post# of 21574
Wow, thanks for this post, coach.

This assessment of a sigma-1 receptor drug similar to AVXL's 2-73 should really put the nail in the coffin on that class of drugs. No wonder the market doesn't view their pipeline as holding promise.

As we progress towards late August results, the market will realize that NTRP may be the only game in town in the Alzheimer's arena.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent TAOX News
More TAOX News